Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026)
Bicycle Therapeutics posted quarterly Asset Utilization Ratio of 0.09 for Q1 2026, up 231.68% year-on-year from 0.03 in Q1 2025, and down 5.4% on a QoQ basis from 0.1 in Q4 2025.
Bicycle Therapeutics (BCYC) has 8 years of Asset Utilization Ratio data on file, last reported at 0.09 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 231.68% year-over-year to 0.09; the trailing twelve-month figure through Mar 2026 stood at 0.09 (up 231.68% YoY), and the FY2025 full-year result was 0.09, up 90.75% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.09, down from 0.1 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.1 in Q4 2025 and bottomed at 0.02 in Q2 2025.
- The 5-year median for Asset Utilization Ratio is 0.04 (2022), against an average of 0.05.
- The widest annual swing landed in 2022, when Asset Utilization Ratio plunged 57.13%; it then jumped 266.09% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2022, then retreated by 23.65% to 0.04 in 2023, then sank by 38.78% to 0.03 in 2024, then surged by 266.09% to 0.1 in 2025, then slipped by 5.4% to 0.09 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.09 (Q1 2026), 0.1 (Q4 2025), and 0.04 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.85 |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.05 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.06 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.08 |
| Jun 30, 2020 | 0.07 |
| Mar 31, 2020 | 0.07 |
| Dec 31, 2019 | 0.12 |
| Sep 30, 2019 | 0.08 |